Abstract
ObjectiveThe 45,X/46,XY and 45,X/47,XYY group of patients includes some of those previously diagnosed with ‘mixed gonadal dysgenesis’. Our aim was to establish the clinical and gonadal spectrum, and early surgical management, of patients with chromosomal mosaicism presenting with genital anomalies. Patients and methodsWe performed a retrospective review of patients with 45,X/46,XY or 45,X/47,XYY mosaicism presenting with genital ambiguity between 1988 and 2009. At least one gonadal biopsy or gonadectomy specimen was available for each patient. Gonadal histology was re-evaluated by a paediatric pathologist. ResultsOf 31 patients with 45,X/46,XY (n = 28) or 45,X/47,XYY (n = 3) mosaicism and genital anomalies, 19 (61%) were raised male. Histology of 46 gonads was available from patients who had undergone a gonadectomy or gonadal biopsy, at a median age of 9.5 months. 18 gonads were palpable at presentation, including 5 (28%) histologically unremarkable testes, 2 streak gonads, and 1 dysgenetic gonad with distinct areas of testicular and ovarian stroma but no oocytes. All intra-abdominal gonads were found to be dysgenetic testes (of which 2 were noted to have pre-malignant changes) or streaks, apart from 1 histologically unremarkable testis. 15 (48%) patients had other anomalies, most commonly cardiac and renal; 4 (13%) had a Turner phenotype. ConclusionThe anatomy and gonadal histology of 45,X/46,XY and 45,X/47,XYY individuals with genital ambiguity do not conform to a set pattern, and hence management of each patient should be individualized according to detailed anatomical and histological assessment.
Highlights
The 2006 consensus statement on the management of disorders of sex development (DSD) introduced the concept of a DSD classification based on karyotype
The anatomy and gonadal histology of 45,X/46,XY and 45,X/47,XYY individuals with genital ambiguity do not conform to a set pattern, and management of each patient should be individualized according to detailed anatomical and histological assessment
Prior to the consensus statement, patients with 45,X/46,XY and 45,X/47,XYY mosaicism presenting with genital anomalies would have been diagnosed with ‘mixed gonadal dysgenesis’ (MGD)
Summary
The 2006 consensus statement on the management of disorders of sex development (DSD) introduced the concept of a DSD classification based on karyotype. This consensus included ‘45,X/46,XY and 45,X/47,XYY (mixed gonadal dysgenesis, ovotesticular DSD)’ patients in the sex chromosome DSD group [1]. Prior to the consensus statement, patients with 45,X/46,XY and 45,X/47,XYY mosaicism presenting with genital anomalies would have been diagnosed with ‘mixed gonadal dysgenesis’ (MGD). Published case series of MGD have included patients with 45,X/ 46,XY and 45,X/47,XYY karyotypes, as well as 46,XY [2e4]. The aim of our study was to review the clinical and gonadal features and early surgical management of patients with 45,X/46,XY and 45,X/ 47,XYY chromosomal mosaicism presenting with genital anomalies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.